The terms we, us, our, Dar or the Company refer collectively to Dar Bioscience, Inc. and its wholly-owned subsidiaries, unless otherwise stated or the context otherwise requires. All information in this report is based on our fiscal year. Unless otherwise stated, references to particular years, quarters, months or periods refer to our fiscal years ending December 31 and the associated quarters, months and periods of those fiscal years. Overview We are a purpose-driven health biotech company sole...
Q2 FY2026 — expected 2026-09-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-26 | 2025-12-31 | 0001401914-26-000004 | EDGAR | 136K words |
| 2025-03-31 | 2024-12-31 | 0001401914-25-000012 | EDGAR | — |
| 2024-03-28 | 2023-12-31 | 0001401914-24-000016 | EDGAR | — |
| 2023-03-30 | 2022-12-31 | 0001401914-23-000013 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0001401914-22-000032 | EDGAR | — |
| 2021-03-30 | 2020-12-31 | 0001401914-21-000041 | EDGAR | — |
| 2020-03-27 | 2019-12-31 | 0001401914-20-000042 | EDGAR | — |
| 2019-04-01 | 2018-12-31 | 0001401914-19-000015 | EDGAR | — |
| 2018-03-28 | 2017-12-31 | 0001564590-18-006989 | EDGAR | — |
| 2017-03-31 | 2016-12-31 | 0001564590-17-005798 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001401914-25-000050 | EDGAR | 32K words |
| 2025-08-14 | 2025-06-30 | 0001401914-25-000044 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0001401914-25-000022 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001401914-24-000041 | EDGAR | — |
| 2024-08-12 | 2024-06-30 | 0001401914-24-000038 | EDGAR | — |
| 2024-05-14 | 2024-03-31 | 0001401914-24-000033 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001401914-23-000048 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0001401914-23-000045 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001401914-23-000023 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001401914-22-000087 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001401914-22-000075 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0001401914-22-000051 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-24 | 0001493152-26-034483 | EDGAR | — |
| 2026-07-17 | 0001401914-26-000040 | EDGAR | — |
| 2026-07-13 | 0001493152-26-032963 | EDGAR | — |
| 2026-03-26 | 0001493152-26-012902 | EDGAR | 5K words |
| 2026-03-17 | 0001493152-26-010594 | EDGAR | — |
| 2026-03-09 | 0001493152-26-009364 | EDGAR | — |
| 2026-03-02 | 0001493152-26-008451 | EDGAR | — |
| 2026-01-29 | 0001493152-26-004245 | EDGAR | — |
| 2026-01-06 | 0001493152-26-000513 | EDGAR | — |
| 2025-12-01 | 0001493152-25-025491 | EDGAR | — |
310 total filings indexed. 278 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001401914 |
| Ticker | DARE |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.darebioscience.com |
| Listed | 2014-04-10 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/DARE (~200 tokens, structured JSON with cryptographic provenance)